--%> ICGI Articles

ICGI Articles

  • A comparison of methods for fully automatic segmentation of tumors and involved nodes in PET/CT of head and neck cancers

    Published: 04.03.2021

    Groendahl AR, Skjei Knudtsen I, Huynh BN, Mulstad M, Moe YM, Knuth F, Tomic O, Indahl UG, Torheim T, Dale E, Malinen E, Futsaether CM

    Phys Med Biol, 66 (6), 065012

    PubMed 33666176

    For more information, please contact:

  • Designing deep learning studies in cancer diagnostics

    Published: 28.01.2021

    Kleppe A, Skrede OJ, De Raedt S, Liestøl K, Kerr DJ, Danielsen HE

    Nat Rev Cancer, 21 (3), 199-211

    PubMed 33514930

    For more information, please contact:

  • Prognostic Value of the Diversity of Nuclear Chromatin Compartments in Gynaecological Carcinomas

    Published: 25.11.2020

    Kleppe A, Albregtsen F, Trovik J, Kristensen GB, Danielsen HE

    Cancers (Basel), 12 (12)

    Pubmed 33352679

    For more information, please contact:

  • Deep learning for prediction of colorectal cancer outcome: a discovery and validation study

    Published: 31.01.2020

    Skrede OJ, De Raedt S, Kleppe A, Hveem TS, Liestøl K, Maddison J, Askautrud HA, Pradhan M, Nesheim JA, Albregtsen A, Farstad IN, Domingo E, Church DN, Nesbakken A, Shepherd NA, Tomlinson I, Kerr R, Novelli M, Kerr DJ, Danielsen HE

    Lancet, 395 (10221), 350-360

    Pubmed 32007170

    For more information, please contact:

  • Prognostic value of DNA ploidy and automated assessment of stroma fraction in prostate cancer

    Published: 16.12.2019

    Ersvaer E, Hveem TS, Vlatkovic L, Brennhovd B, Kleppe A, Tobin KAR, Pradhan M, Cyll K, Waehre H, Kerr DJ, Danielsen HE (2019)

    Int J Cancer

    PubMed 31846064

    For more information, please contact:

  • Prognostic value of mitotic checkpoint protein BUB3, cyclin B1, and pituitary tumor-transforming 1 expression in prostate cancer

    Published: 03.12.2019

    Ersvær E, Kildal W, Vlatkovic L, Cyll K, Pradhan M, Kleppe A, Hveem TS, Askautrud HA, Novelli M, Wæhre H, Liestøl K, Danielsen HE

    Mod Pathol Dec 4 2019

    PubMed 31801961

    For more information, please contact:

  • Clinical utility of chromatin analysis

    Published: 20.08.2018

    For more information, please contact:

  • Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series

    Published: 01.07.2018

    Domingo E, Camps C, Kaisaki PJ, Parsons MJ, Mouradov D, Pentony MM, Makino S, Palmieri M, Ward RL, Hawkins NJ, Gibbs P, Askautrud H, Oukrif D, Wang H, Wood J, Tomlinson E, Bark Y, Kaur K, Johnstone EC, Palles C, Church DN, Novelli M, Danielsen HE, Sherlock J, Kerr D et al.

    Lancet Gastroenterol Hepatol

    PubMed 30042065

    For more information, please contact:

  • Association Between Proportion of Nuclei With High Chromatin Entropy and Prognosis in Gynecological Cancers

    Published: 17.04.2018

    Nielsen B, Kleppe A, Hveem TS, Pradhan M, Syvertsen RA, Nesheim JA, Kristensen GB, Trovik J, Kerr DJ, Albregtsen F, Danielsen HE

    J Natl Cancer Inst. 2018 Apr 18. doi: 10.1093/jnci/djy063

    PubMed 29684152

    For more information, please contact:

  • Chromatin organisation and cancer prognosis: a pan-cancer study

    Published: 31.01.2018

    Kleppe A, Albregtsen F, Vlatkovic L, Pradhan M, Nielsen B, Hveem TS, Askautrud HA, Kristensen GB, Nesbakken A, Trovik J, Wæhre H, Tomlinson I, Shepherd NA, Novelli M, Kerr DJ, Danielsen HE

    Lancet Oncol DOI: https://doi.org/10.1016/S1470-2045(17)30899-9

    PubMed 29402700

    For more information, please contact:

  • « 1 2 Previous Next » 

Chief Editor: Prof. Håvard E. Danielsen
Copyright Oslo University Hospital. Visiting address: The Norwegian Radium Hospital, Ullernchausséen 64, Oslo. Tel: 22 78 23 20